Clinical Trials in Detroit

Showing 9261-9280 of 14,997 trials

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

NCT03119467

A Phase I/Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients with Relapsed or Refractory Lymphomas

Rhizen Pharmaceuticals SA21 participantsStarted May 2017

Birmingham, Alabama, United States • Duarte, California, United States • Aurora, Colorado, United States +8 more locations

COMPLETEDPhase 2< 1 mile

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma

NCT01984242

This multicenter, randomized, open-label study will evaluate the efficacy, safety and tolerability of atezolizumab as monotherapy or in combination with bevacizumab versus sunitinib in participants with histologically confirmed, inoperable, locally advanced or metastatic renal cell carcinoma who have not received prior systemic therapy either in the adjuvant or metastatic setting.

Renal Cell Carcinoma

Hoffmann-La Roche305 participantsStarted Jan 2014

Scottsdale, Arizona, United States • Duarte, California, United States • Los Angeles, California, United States +42 more locations

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma

Find Trials by Condition in Detroit

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

12-Week Study of Plecanatide for CIC (The CIC3 Study)

Pediatric Open-Label Extension Study

Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder

Quality Improvement and Personalization for Statins

The Use of D5LR Versus LR for Induction of Labor and Time to Delivery in Multiparous and Primiparous Patient's With Favorable and Unfavorable Bishop's Scores

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer